Haver V M, Namm D H
Blood Vessels. 1983;20(2):92-8.
A stimulant of vascular smooth muscle contraction was generated in fresh, citrated human plasma during activation of the clotting system. Plasma, exposed briefly to thromboplastin and Ca++, induced a contraction of isolated rabbit aorta and dog coronary arteries that was slow in development and persisted after washout. The contractile activity was not blocked by phenoxybenzamine, atropine, or angiotensin inhibitor, but was blocked when heparin or hirudin was incubated with the plasma. The contractile stimulant produced in the plasma was short-lived (less than 3 min) and paralleled the appearance of thrombin in plasma. Purified human alpha-thrombin also induced a sustained contraction in these blood vessels that was not inhibited by phenoxybenzamine, atropine, or angiotensin inhibitor, but was blocked by hirudin. Partial relaxation of the thrombin-treated blood vessel was achieved by the addition of heparin. These results suggest that this vasoactive component of thromboplastin-activated human plasma is alpha-thrombin. Because of its potent and persistent effects, thrombin-induced vasospasm may be an important mechanism in the etiology of ischemic heart disease.
在凝血系统激活过程中,新鲜的、枸橼酸化的人血浆中会产生一种血管平滑肌收缩刺激物。将血浆短暂暴露于凝血酶原激酶和钙离子下,会诱导离体兔主动脉和犬冠状动脉收缩,这种收缩发展缓慢,冲洗后仍持续存在。这种收缩活性不受苯氧苄胺、阿托品或血管紧张素抑制剂的阻断,但当肝素或水蛭素与血浆一起孵育时,收缩活性被阻断。血浆中产生的收缩刺激物寿命短暂(少于3分钟),且与血浆中凝血酶的出现平行。纯化的人α-凝血酶也会诱导这些血管持续收缩,这种收缩不受苯氧苄胺、阿托品或血管紧张素抑制剂的抑制,但被水蛭素阻断。通过添加肝素可使经凝血酶处理的血管部分松弛。这些结果表明,凝血酶原激酶激活的人血浆中的这种血管活性成分是α-凝血酶。由于其强大而持久的作用,凝血酶诱导的血管痉挛可能是缺血性心脏病病因中的一个重要机制。